Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics
- 1 May 2006
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 16 (3) , 1234-1240
- https://doi.org/10.1111/j.1525-1438.2006.00522.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- CpG Islands in vertebrate genomesPublished by Elsevier ,2004
- Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumorsBiochemical and Biophysical Research Communications, 2004
- Detection of hypermethylated genes in tumor and plasma of cervical cancer patientsGynecologic Oncology, 2004
- DNA Methylation in Serum and Tumors of Cervical Cancer PatientsClinical Cancer Research, 2004
- Frequent hypermethylation of 5′ flanking region of TIMP‐2 gene in cervical cancerInternational Journal of Cancer, 2004
- CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patientsInternational Journal of Cancer, 2003
- DNA methylation patterns and epigenetic memoryGenes & Development, 2002
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- G1 phase progression: Cycling on cueCell, 1994
- CpG-rich islands and the function of DNA methylationNature, 1986